StemCyte - A Global Regenerative Therapeutics Company Revenue and Competitors
Estimated Revenue & Valuation
- StemCyte - A Global Regenerative Therapeutics Company's estimated annual revenue is currently $28.7M per year.
- StemCyte - A Global Regenerative Therapeutics Company's estimated revenue per employee is $143,000
Employee Data
- StemCyte - A Global Regenerative Therapeutics Company has 201 Employees.
- StemCyte - A Global Regenerative Therapeutics Company grew their employee count by 5% last year.
StemCyte - A Global Regenerative Therapeutics Company's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | National Manager | Reveal Email/Phone |
4 | Regional Manager | Reveal Email/Phone |
5 | Phlebotomist | Reveal Email/Phone |
6 | Customer Service Representative II | Reveal Email/Phone |
7 | Lab technician | Reveal Email/Phone |
8 | National Sales Director | Reveal Email/Phone |
9 | Regional Sales Manager | Reveal Email/Phone |
10 | Remote Sales /Cord Blood Education DFW and Austin, Social Media Community Management | Reveal Email/Phone |
StemCyte - A Global Regenerative Therapeutics Company Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1770.7M | 9525 | 16% | $2.3B | N/A |
#2 | $21.6M | 151 | -3% | N/A | N/A |
#3 | $5.2M | 50 | 14% | N/A | N/A |
#4 | $5920M | 6292 | 0% | $552.3M | N/A |
#5 | $1M | 13 | -41% | N/A | N/A |
#6 | $6.4M | 55 | 8% | N/A | N/A |
#7 | $1.6M | 25 | -44% | $44M | N/A |
#8 | $1.4M | 21 | 0% | $4.7M | N/A |
#9 | $2.5M | 28 | -10% | N/A | N/A |
#10 | $3.5M | 34 | -6% | N/A | N/A |
What Is StemCyte - A Global Regenerative Therapeutics Company?
Located in the US, India and Taiwan, StemCyte has established one of the largest, most racially diverse, and highest quality cord blood stem cell banks in the world. StemCyte has supplied more than 2,000 cord blood units to treat life-threatening diseases in more than 350 transplant centers worldwide. StemCyte is actively involved in the development of new umbilical cord blood-based cell therapies and the development of trials investigating regenerative spinal cord therapies. StemCyte is one of the only for-profit companies contracted by the US Department of HHS to help contribute clinical grade cord blood units to the public National Cord Blood Inventory for unrelated transplants. Its headquarters are in Baldwin Park, California. To learn more visit www.StemCyte.com.
keywords:N/A
N/A
Total Funding
201
Number of Employees
$28.7M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
StemCyte - A Global Regenerative Therapeutics Company News
Due to their regenerative properties, stem cells are being researched for therapeutic applications in diabetes, cardiovascular disease,...
Cord Blood America Inc. Stem Cyte; Aldagen; Arteriocyte; Brainstorm Cell Therapeutics. For more information about this report visit https://www.
Cord Blood America Inc. Stem Cyte; Aldagen; Arteriocyte; Brainstorm Cell Therapeutics. For more information about this report visit https://www.
Other Companies in Baldwin Park
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $101.9M | 302 | 3% | N/A |
#2 | $148.3M | 339 | 2% | N/A |
#3 | $107.7M | 594 | 3% | N/A |